Richard Meyer

The vast majority of patients expect patient services

screenshot_4576% of patients think pharmaceutical companies have a responsibility to provide information and services that help patients manage their own health.   Nearly as many respondents— 74%—indicate that the most appropriate time to initiate outreach is when they start taking a medication, although half of the respondents are open to receiving assistance after they have begun a course of treatment or are considering switching.

Continue reading »

The birth of the healthcare consumer

screenshot_33There’s a new boss in U.S. healthcare: the consumer according to a survey of 2,339 U.S. residents .The research paints a clear picture of a population displeased with its overall healthcare experience — and with rising expectations for transparency, value, and customer service, as well as a willingness to seek healthcare services from less traditional sources. The healthcare market as we know it is being upended, and the consumer is in the driver’s seat.  Consumers, particularly younger ones, increasingly expect healthcare to work the way other digital markets work, with user-friendly interfaces, clearly defined pricing and wide spread options designed to meet their needs. Their other buying experiences have made them more savvy and skeptical, and they want to know what they’re getting before they spend.

Continue reading »

FDA approval no longer means sales

I was talking to our research Director about some recent research findings and surprisingly one of the top line findings is that both consumers and physicians are not in any hurry to try new drugs just because they were newly approved by the FDA.  Why ?  Trust. Continue reading »

Cost of cancer drugs not the issue

screenshot_26POST SUMMARY: Spending on cancer medicines represents less than 1 percent of all health care spending for all diseases —$25.9 billion out of $2,800 billion. Cancer medicines represent 20 percent of total spending on cancer care.  But don’t let facts get in the way of a good media story. Continue reading »

Time to rethink pharma reps?

docrepsPOST SUMMARY: 32% of physicians said they cannot talk to reps, compared to 27% last year. Apply this limit to doctors in organized health systems, and the restrictions become even greater: 42% of doctors affiliated with integrated health networks say they are not allowed to see reps—a 17% increase since last year.  Time for pharma to rethink reps? Continue reading »

Mobile apps for pharma: Opportunities exists

POST SUMMARY: Developing an app may not the answer for DTC marketers who want to improve bottom line results.  Apps require a lot of money to develop and most patients don’t want to be reminded that they have chronic health problems but there are opportunities for tose willing to blaze new trails NOW. Continue reading »

Will DTC marketers always be laggards?

laggardPOST SUMMARY:  Omnicom Media Group, the global media network that oversees more than $50 billion in annual ad spend for clients such as Apple, Starbucks, McDonald’s and Pepsi, is advising its clients to shift as much as 25% of their TV advertising budgets to online video. Will DTC marketers get the word or will we still be bombarded with drug commercials via the evening news? Continue reading »

Share with your friends










Submit